Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): Risk of concurrent invasive malignancy following a core biopsy diagnosis

Histopathology

Volumn 57, Issue 3, 2010, Pages 472-478

  Carder, Pauline J ^a   Shaaban, Abeer ^a   Alizadeh, Yalda ^b   Kumarasuwamy, Vidya ^c   Liston, Joyce C ^b   Sharma, Nisha ^b  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c CALDERDALE ROYAL HOSPITAL   (United Kingdom)

Author keywords

breast screening; core biopsy; lobular carcinoma in situ; pleomorphic lobular carcinoma in situ

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; NEEDLE BIOPSY; PLEOMORPHIC LOBULAR CARCINOMA IN SITU; PRIORITY JOURNAL; TUMOR VOLUME;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 77956642584     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03634.x     Document Type: Article

References (25)

1. Frost AR, Tsangaris TN, Silverberg SG. Pleomorphic lobular carcinoma in situ. Pathol. Case Rev. 1996 1 27 30.
2. Bentz JS, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod. Pathol. 1998 11 814 822.
3. Middelton LP, Palacious DM, Bryant BR et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry and molecular analysis. Am. J. Surg. Pathol. 2000 24 1650 1656.
4. Sneige N, Wang J, Baker BA et al. Clinical, histopathology and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod. Pathol. 2002 15 1044 1050.
5. Chen Y, Fitzgibbons P, Jacobs T et al. Pleomorphic lobular apocrine carcinoma in situ (PALCIS): phenotypic and genetic study of a distinct variant of lobular carcinoma in situ (LCIS). Lab. Invest. 2005 85 29A.
6. Elsheikh TM, Silverman JF. Follow up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am. J. Surg. Pathol. 2005 29 534 543.
7. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. AJR Am. J. Roentgenol. 2006 187 949 954.
8. Menon S, Porter GJ, Evans AJ et al. The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch. 2008 452 473 479.
9. Chivukula M, Haynik DM, Brufsky A et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast needle core biopsy: clinical significance and immunoprofile. Am. J. Surg. Pathol. 2008 32 1721 1726.
10. Reis-Filho JS, Pinder S. Non-operative breast pathology: lobular neoplasia. J. Clin. Pathol. 2007 60 1321 1327.
11. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch. 2002 440 134 138.
12. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular patterns carcinoma in situ) of the breast. Cancer 1978 42 737 769.
13. Eusebi V, Betts C, Haagenson DE et al. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic and ultrastructural study. Hum. Pathol. 1984 15 134 140.
14. Koerner F, Maluf H. Uncommon morphologic patterns of lobular neoplasia. Ann. Diagn. Pathol. 1999 3 249 259.
15. Karabakhtsian RG, Johnson R, Sumkin J, Dabbs DJ. The clinical significance of lobular neoplasia on breast core biopsy. Am. J. Surg. Pathol. 2007 31 717 723.
16. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch. Pathol. Lab. Med. 2002 126 697 701.
17. Crisi GM, Mandavilli S, Cronin E, Ricci A. Invasive mammary carcinoma after immediate and short term follow-up for lobular neoplasia on core biopsy. Am. J. Surg. Pathol. 2003 27 325 333.
18. Dmytrasz K, Tatter Pl, Mizrachy H et al. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J. 2003 9 10 12.
19. Foster MC, Helvie MA, Gregory NE et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core needle biopsy: is excisional biopsy necessary. Radiology 2004 231 813 819.
20. Liberman L, Sama M, Susnik B. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am. J. Roentgenol. 1999 173 291 299.
21. O'Driscoll D, Britton P, Bobrow L et al. Lobular carcinoma in situ on core biopsy - what is the clinical significance. Clin. Radiol. 2001 56 216 220.
22. Renshaw AA, Cartagena N, Derhagopian RP et al. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am. J. Clin. Pathol. 2002 117 797 799.
23. Hwang H, Barke LD, Mendelson EB et al. Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod. Pathol. 2008 21 1208 1216.
24. Simpson PT, Reis-Filho JS, Gale T et al. Molecular evolution of breast cancer. J. Pathol. 2005 205 248 254.
25. Simpson P, Reis-Filho JS, Lambros MB et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J. Pathol. 2008 215 231 244.